Synapse - Kevin Curran

Search Within

Kevin Joseph Curran

Results (31)

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Journal Article

Fabrizio, V. A.; Boelens, J. J.; Mauguen, A.; Baggott, C.; Prabhu, S.; Egeler, E.; Mavroukakis, S.; Pacenta, H.; Phillips, C. L.; Rossoff, J.; more...
Blood Advances (2022)

Fulltext@MSK | Save

Impact of bridging chemotherapy on clinical outcomes of CD19-specific CAR T cell therapy in children/young adults with relapsed/refractory B cell acute lymphoblastic leukemia

Journal Article

Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Perica, K.; Park, J. H.; Forlenza, C. J.; Shukla, N. N.; Steinherz, P. G.; Margossian, S. P.; more...
Transplantation and Cellular Therapy (2022)

Fulltext@MSK | Save

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation

Journal Article

Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Ruiz, J. D.; Klein, E.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; more...
Blood Advances (2022)

Fulltext@MSK | Save

Bridging chemotherapy prior to CD19-specific CAR T-cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia

Meeting Abstract

Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Boelens, J. J.; Forlenza, C.; Kernan, N.; Shukla, N.; Steinherz, P.; Sulis, M. L.; more...
Pediatric Blood and Cancer (2021)

Fulltext@MSK | Save

Decreased neuroprotective analytes on day of infusion of chimeric antigen receptor (CAR) T cells are associated with neurotoxicity

Meeting Abstract

Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Khakoo, Y.; Santomasso, B. D.; Riviere, I.; Sadelain, M.; Curran, K. J.; more...
Bone Marrow Transplantation (2021)

Fulltext@MSK | Save

Predictors for neurotoxicity on day of infusion of chimeric antigen receptor (CAR) T cells using discovery proteomics platform

Meeting Abstract

Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Auchincloss, T.; Klein, E.; Khakoo, Y.; Santomasso, B.; Senechal, B.; more...
Cytotherapy (2021)

Fulltext@MSK | Save

Fludarabine-exposure predicts disease control following CD19-specific CAR T cell (tisagenlecleucel); A report from pediatric real-world CAR Consortium

Meeting Abstract

Curran, K. J.; Fabrizio, V. A.; Mauguen, A.; Boelens, J. J.; Baggott, C.; Prabhu, S.; Placenta, H.; Phillips, C. L.; Rossoff, J.; Stefanski, H.; more...
Cytotherapy (2021)

Fulltext@MSK | Save

Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults

Meeting Abstract

Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
Blood (2020)

Fulltext@MSK | Save

Rabbit anti-thymocyte globulin (ATG) exposure after ex vivo T-cell-depleted hematopoietic cell transplantation is variable and impacts immune reconstitution and survival in children and young adults

Meeting Abstract

Lakkaraja, M.; Mauguen, A.; Boulad, F.; Spitzer, B.; Scaradavou, A.; Curran, K.; Cancio, M.; Roessel, I.; Klein, E.; Kernan, N.; more...
Bone Marrow Transplantation (2020)

Fulltext@MSK | Save

Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant

Journal Article

Fabrizio, V. A.; Kernan, N. A.; Boulad, F.; Cancio, M.; Allen, J.; Higman, M.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; more...
Bone Marrow Transplantation (2020)

Fulltext@MSK | Save